Immatics receives Pfizer's 'support' for pivotal IMA901 trial in RCC
12 April 2011
Pial Ganguli
Please Login to read the full article.
12 April 2011
Pial Ganguli
Please Login to read the full article.
RELATED CONTENT
NEWS
- AVEO's unconvincing Phase II ficlatuzumab data point to need for further studies
- Argos to begin Phase III of renal carcinoma drug in combination with sunitinib
- Argos passes on IPO and raises $25m Series D to fund personalized cancer immunotherapy
- Abbott outlines pharma growth strategies
ANALYSIS
Other Informa Analysis
EVENTS
07 June 2012
The Rembrandt Hotel, London
12 June 2012
Annecy, France
18 June 2012
Boston Convention & Exhibition Center, Boston, MA
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
